Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Corporativo FraguaB de CVMEX:FRAGUAB +3.44%84 ROC (Joel Greenblatt) % is 21.53% as of Dec. 2024, which is 16% below its 10-year median of 25.69. GuruFocus rates MEX:FRAGUAB with a GF Score™ of 84/100 and a GF Value™ of MXN697.68 (Significantly Undervalued). Among 665 Healthcare Providers & Services companies, Corporativo FraguaB de CV ranks better than 65.11% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Corporativo FraguaB de CV's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 21.53%.
The historical rank and industry rank for Corporativo FraguaB de CV's ROC (Joel Greenblatt) % or its related term are showing as below:
MEX:FRAGUAB'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 21.53 Med: 25.69 Max: 44.01
Current: 21.53
During the past 13 years, Corporativo FraguaB de CV's highest ROC (Joel Greenblatt) % was 44.01%. The lowest was 21.53%. And the median was 25.69%.
MEX:FRAGUAB's ROC (Joel Greenblatt) % is ranked better than 65.11% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 12.49
vs MEX:FRAGUAB: 21.53
Corporativo FraguaB de CV's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 2.00% per year.
Corporativo FraguaB de CV (MEX:FRAGUAB) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Corporativo FraguaB de CV ROC (Joel Greenblatt) % Related Terms
Corporativo FraguaB de CV ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Corporativo FraguaB de CV's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV ROC (Joel Greenblatt) % Chart
Corporativo FraguaB de CV ROC (Joel Greenblatt) % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Corporativo FraguaB de CV's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corporativo FraguaB de CV ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Corporativo FraguaB de CV's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Corporativo FraguaB de CV's ROC (Joel Greenblatt) % falls into.
Corporativo FraguaB de CV ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is one times the annual (Dec. 2024) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 21.53% mean?
Corporativo FraguaB de CV (MEX:FRAGUAB) has a ROC (Joel Greenblatt) % of 21.53% as of Dec. 2024. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Corporativo FraguaB de CV and its competitors. This is 16% below median its historical median of 25.69. Over the past decade, Corporativo FraguaB de CV's ROC (Joel Greenblatt) % has ranged from 21.53 to 44.01. According to the industry distribution chart, Corporativo FraguaB de CV ranks #232 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 34.9%.
Is Corporativo FraguaB de CV's ROC (Joel Greenblatt) % too high?
Corporativo FraguaB de CV's current ROC (Joel Greenblatt) % of 21.53% is 16% below median its 10-year median of 25.69. Over the past 10 years, this metric has ranged from a low of 21.53 to a high of 44.01. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.49. Corporativo FraguaB de CV's value of 21.53% is 72.4% above this industry median. Based on the distribution chart, Corporativo FraguaB de CV ranks #232 out of 665 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Corporativo FraguaB de CV has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Corporativo FraguaB de CV's ROC (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Corporativo FraguaB de CV ranks #232 out of 665 companies for ROC (Joel Greenblatt) %. This puts Corporativo FraguaB de CV in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.49. Corporativo FraguaB de CV's value of 21.53% is 72.4% above this benchmark. Historically, Corporativo FraguaB de CV's own ROC (Joel Greenblatt) % has ranged from 21.53 to 44.01 over the past decade. While the company's 10-year median is 25.69 vs. the industry median of 12.49, Corporativo FraguaB de CV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.49, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Corporativo FraguaB de CV's current ROC (Joel Greenblatt) % of 21.53% is 72.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Corporativo FraguaB de CV and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corporativo FraguaB de CV's current ROC (Joel Greenblatt) % is 21.53%, which is 16% below median its own 10-year median of 25.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corporativo FraguaB de CV stock overvalued right now?
Based on GuruFocus' analysis, Corporativo FraguaB de CV (MEX:FRAGUAB) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN697.68, compared to a current price of MXN479.99 — trading 31.2% below its estimated fair value. The current ROC (Joel Greenblatt) % is 21.53%, which is 16% below median its 10-year median of 25.69 and 72.4% above the Healthcare Providers & Services industry median of 12.49. Corporativo FraguaB de CV's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Corporativo FraguaB de CV (MEX:FRAGUAB), the current ROC (Joel Greenblatt) % is 21.53% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Corporativo FraguaB de CV (MEX:FRAGUAB) Overvalued in 2026?
Based on GuruFocus' analysis, Corporativo FraguaB de CV stock appears to be undervalued.
The current stock price of MXN479.99 is trading 31.2% below its estimated GF Value™ of MXN697.68.
GuruFocus considers Corporativo FraguaB de CV to be Significantly Undervalued.
Key valuation signals for MEX:FRAGUAB:
ROC (Joel Greenblatt) %: 21.53% (16% below median its 10-year median of 25.69)
GF Value™: MXN697.68 vs. price of MXN479.99 (31.2% below fair value)
Industry Position: 72.4% above the Healthcare Providers & Services median (#232 of 665)
No single metric tells the full story. See the MEX:FRAGUAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
84GF Score
Get the complete analysis for MEX:FRAGUAB
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:FRAGUAB has been successfully added to your 
